|
1
|
Pecorelli S, Favalli G, Zigliani L and
Odicino F: Cancer in women. Int J Gynaecol Obstet. 82:369–379.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ozols RF: Update on the management of
ovarian cancer. Cancer J. 8(Suppl 1): S22–S30. 2002.PubMed/NCBI
|
|
3
|
Ozols RF: Treatment goals in ovarian
cancer. Int J Gynecol Cancer. 15(Suppl 1): 3–11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ozols RF, Bookman MA, Connolly DC, Daly
MB, Godwin AK, Schilder RJ, Xu X and Hamilton TC: Focus on
epithelial ovarian cancer. Cancer Cell. 5:19–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou BB, Zhang H, Damelin M, Geles KG,
Grindley JC and Dirks PB: Tumour-initiating cells: Challenges and
opportunities for anticancer drug discovery. Nat Rev Drug Discov.
8:806–823. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gottesman MM: Mechanisms of cancer drug
resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schatton T, Murphy GF, Frank NY, Yamaura
K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM,
Weishaupt C, et al: Identification of cells initiating human
melanomas. Nature. 451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J and Song E: let-7 regulates
self renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is amolecular
determinant of the side-population phenotype. Nature Med.
7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito K, Hirao A, Arai F, Matsuoka S, Takubo
K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K and Nakagata N:
Regulation of oxidative stress by ATM isrequired for self-renewal
of haematopoietic stem cells. Nature. 31:997–1002. 2004. View Article : Google Scholar
|
|
13
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp
Med. 183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meirelles K, Benedict LA, Dombkowski D,
Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin
DT, Donahoe PK and Wei X: Human ovarian cancer stem/progenitor
cells are stimulated by doxorubicin but inhibited by Mullerian
inhibiting substance. Proc Natl Acad Sci USA. 109:2358–2363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christgen M, Geffers R, Ballmaier M,
Christgen H, Poczkaj J, Krech T, Kreipe H and Lehmann U:
Down-regulation of the fetal stem cell factor SOX17 by H33342: A
mechanism responsible for differential gene expression in breast
cancer side population cells. J Biol Chem. 285:6412–6418. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oates JE, Grey BR, Addla SK, Samuel JD,
Hart CA, Ramani VA, Brown MD and Clarke NW: Hoechst 33342 side
population identification is a conserved and unified mechanism in
urological cancers. Stem Cells Dev. 18:1515–1522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo Y, Ellis LZ, Dallaglio K, Takeda M,
Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R,
et al: Side population cells from human melanoma tumors reveal
diverse mechanisms for chemoresistance. J Invest Dermatol.
132:2440–2450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mas A, Cervelló I, Gil-Sanchis C, Faus A,
Ferro J, Pellicer A and Simón C: Identification and
characterization of the human leiomyoma side population as putative
tumor-initiating cells. Fertil Steril. 98:741–751, e6. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dou J, Jiang C, Wang J, Zhang X, Zhao F,
Hu W, He X, Li X, Zou D and Gu N: Using ABCG2-molecule-expressing
side population cells to identify cancer stem-like cells in a human
ovarian cell line. Cell Biol Int. 35:227–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
Inhibiting Substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang S, Balch C, Chan MW, Lai HC, Matei
D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and
characterization of ovarian cancer-initiating cells from primary
human tumors. Cancer Res. 68:4311–4320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jakubikova J, Adamia S, Kost-Alimova M,
Klippel S, Cervi D, Daley JF, Cholujova D, Kong SY, Leiba M, Blotta
S, et al: Lenalidomide targets clonogenic side population in
multiple myeloma: Pathophysiologic and clinical implications.
Blood. 117:4409–4419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Douglas EJ, Fiegler H, Rowan A, Halford S,
Bicknell DC, Bodmer W, Tomlinson IP and Carter NP: Array
comparative genomic hybridization analysis of colorectal cancer
cell lines and primary carcinomas. Cancer Res. 64:4817–4825. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang SL, Wang YS, Zhou T, Yu XW, Wei ZT
and Li YL: Isolation and characterization of cancer stem cells from
cervical cancer HeLa cells. Cytotechnology. 64:477–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
34
|
Baba T, Convery PA, Matsumura N, Whitaker
RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, et al:
Epigenetic regulation of CD133 and tumorigenicity of
CD133+ ovarian cancer cells. Oncogene. 28:209–218. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Burkert J, Otto WR and Wright NA: Side
populations of gastrointestinal cancers are not enriched in stem
cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kai K, D'Costa S, Yoon BI, Brody AR, Sills
RC and Kim Y: Characterization of side population cells in human
malignant mesothelioma cell lines. Lung Cancer. 70:146–151. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mitsutake N, Iwao A, Nagai K, Namba H,
Ohtsuru A, Saenko V and Yamashita S: Characterization of side
population in thyroid cancer cell lines: Cancer stem-like cells are
enriched partly but not exclusively. Endocrinology. 148:1797–1803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lichtenauer UD, Shapiro I, Geiger K,
Quinkler M, Fassnacht M, Nitschke R, Rückauer KD and Beuschlein F:
Side population does not define stem cell-like cancer cells in the
adrenocortical carcinoma cell line NCI h295R. Endocrinology.
149:1314–1322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone
H, Kandel R, Wunder JS and Alman BA: Side population cells isolated
from mesenchymal neoplasms have tumor initiating potential. Cancer
Res. 67:8216–8222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rizzo S, Hersey JM, Mellor P, Dai W,
Santos-Silva A, Liber D, Luk L, Titley I, Carden CP, Box G, et al:
Ovarian cancer stem cell-like side populations are enriched
following chemotherapy and overexpress EZH2. Mol Cancer Ther.
10:325–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu L, McArthur C and Jaffe RB: Ovarian
cancer stem-like side-population cells are tumourigenic and
chemoresistant. Br J Cancer. 102:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moreno-Smith M, Halder JB, Meltzer PS,
Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM,
Kang Y, et al: ATP11B mediates platinum resistance in ovarian
cancer. J Clin Invest. 123:2119–2130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Januchowski R, Zawierucha P, Andrzejewska
M, Ruciński M and Zabel M: Microarray-based detection and
expression analysis of ABC and SLC transporters in drug-resistant
ovarian cancer cell lines. Biomed Pharmacother. 67:240–245. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen Y, Li D, Wang D, Liu X, Yin N, Song
Y, Lu SH, Ju Z and Zhan Q: Quiescence and attenuated DNA damage
response promote survival of esophageal cancer stem cells. J Cell
Biochem. 113:3643–3652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li XX, Dong Y, Wang W, Wang HL, Chen YY,
Shi GY, Yi J and Wang J: Emodin as an effective agent in targeting
cancer stem-like side population cells of gallbladder carcinoma.
Stem Cells Dev. 22:554–566. 2013. View Article : Google Scholar : PubMed/NCBI
|
